AlphaPet Ventures GmbH
Peter Meyer is a seasoned finance professional with extensive experience in financial leadership across various companies. Currently serving as Leitung Finanzbuchhaltung at OPED GmbH since February 2023, Peter has previously held key positions including Lead Sales Finance - Senior Finance Partner D_A_CH at GSK from April 2016 to January 2023, and Head of Finance for Germany & Austria at Eli Lilly and Company from January 2015 to March 2016. Peter's tenure at Novartis includes roles as Head Finance Germany & Austria & Benelux - General Manager and Head Business Planning & Analysis, demonstrating strong capabilities in finance management and departmental leadership. Early career experience includes positions in accounting and controlling at Stöbich Brandschutz GmbH and Ing. Friedrich Hanke GmbH. Peter holds a Diplom-Kaufmann degree from The University of Göttingen and an Industriekaufmann qualification from Ing. Friedrich Hanke GmbH.
This person is not in the org chart
This person is not in any teams